NOVAVAX, INC. (NVAX) Operating income 2016–2025
NOVAVAX, INC. (NVAX) annual operating income history from SEC filings — each fiscal year as reported.
$452.8MFY2025 · since FY2016: -$269.1M → $452.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $452.8M | +281.9% |
| FY2024 | -$248.9M | +56.1% |
| FY2023 | -$566.5M | +12.1% |
| FY2022 | -$644.7M | +61.8% |
| FY2021 | -$1.7B | -304.7% |
| FY2020 | -$416.7M | -245.6% |
| FY2019 | -$120.6M | +30.7% |
| FY2018 | -$173.9M | -1.3% |
| FY2017 | -$171.7M | +36.2% |
| FY2016 | -$269.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice